You are here

Offerings On Manhattan Street Capital

Success in hand
Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16th - two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low side effects. The DNA string adjusts cell signaling to trigger cancer cell death. Genprex is raising $6.5 mill at a...
office construction
Newest Reg D offerings on Manhattan Street Capital. For Accredited Investors only. KGEM Golf Investors in KGEM Golf will receive an 8% annual dividend, paid monthly...
City with title
New and Updated Offerings live on Manhattan Street Capital ERC Homebuilders Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of...
Compass towards success
Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment. Genprex has developed Oncoprex, a unique medicine...
Handshake at golf
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings....
investing button
Reg A+ offerings - Anyone can invest   GolfSuites 1 - Anyone can invest "GolfSuites is a new investment opportunity focused on bringing hybrid-golf...
hiking with friend
ERC Homebuilders Inc. - Max raise $50mill. Anyone can invest ERC develops "build-to-rent" homes to capitalize on market demand driven by the cultural wave of millennials...
Pointing at title
Most active Reg A+ offerings on Manhattan Street Capital GolfSuites 1 Investors in GolfSuites 1 receive an 8% per annum dividend (see the Offering Circular for the...
Figures and increase
If you are in the San Diego area: You’re invited to my seminar on July 24, “How to Succeed Raising Capital via a Regulation Compliant ICO/STO.” I’ll speak to all key...